UNSPSC 51432106: Guanoclor

This classification denotes an antihypertensive agent with the molecular formula C9H12Cl2N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M4HBT852YO, chemically known as 2-(2,6-dichlorophenoxy)ethylaminoguanidine sulfate but generally known as guanoclor, which bears US NIH Compound Identifier 71835. European Medicines Agency schedules Guanoclor in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07987MIG.

UNSPSC 51432106 Guanoclor, a Commodity code, does not align with state and local procurement activity currently tracked under it. The single recent opportunity posted under this code—a City of Tampa IFB for Advanced Life Support Medications issued April 24, 2026, with a response deadline of April 8, 2026—solicits emergency medical supplies (Labetalol, Epinephrine, Adenosine, and Diltiazem) for Tampa Fire Rescue, not guanoclor or guanoclor-related products. The $40,000 estimated contract value covers four specific medication line items required to maintain nine-month minimum shelf life, with firm pricing inclusive of shipping and taxes, delivery within ten calendar days, and a one-year initial term plus renewal options.

The source provides no evidence of guanoclor procurement or related pharmaceutical products in recent state and local contracting. The Tampa Fire Rescue opportunity appears to be a code-taxonomy mismatch rather than representative activity. Without additional recent opportunities under this Commodity code in the source material, no geographic pattern, issuing-body concentration, or scope characterization beyond this single misaligned solicitation can be established. Firms evaluating this code should verify the UNSPSC classification against their target product or service scope before pursuing similar opportunities.